Death Becomes Optional

The quest to slow aging has moved from science fiction to serious science, with researchers making unprecedented strides in cellular programming while consumer-friendly supplements like NADs are bringing longevity medicine to the mainstream. We're witnessing an explosion of everything from cutting-edge therapies that reprogram aging at the cellular level to more accessible products promising to help people live healthier, longer lives without requiring a PhD in biochemistry. But as the longevity market reaches fever pitch, companies are discovering that translating complex anti-aging research into products that resonate with everyday consumers, not just the Huberman-listening biohacker crowd, is harder than extending lifespan itself. The current state of longevity research needs a gut check to understand what's genuinely revolutionary, what’s hype, and what's coming next in the race to extend human lifespan. And if we’re still unsure, we can just ask Goldie Hawn what her secret is!